Direct and Indirect Costs Associated with Coronary Artery (Heart) Disease in Tabriz, Iran

References

• Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016;4(13):256. doi:10.21037/atm.2016.06.3327500157
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke Statistics-2019 update a report from the American Heart Association. Circulation. 2019.
   Web of Science ®Google Scholar
• Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics—2020 update: a report from the American Heart Association. Circulation. 2020;E139–E596.31992061
   PubMed Web of Science ®Google Scholar
• Yousefi M, Safari H, Sari AA, Raei B, Ameri H. Assessing the performance of direct and indirect utility eliciting methods in patients with colorectal cancer: EQ-5D-5L versus C-TTO. Health Serv Outcomes Res Methodol. 2019;19(4):259–270. doi:10.1007/s10742-019-00204-5
   Web of Science ®Google Scholar
• Ameri H, Yousefi M, Yaseri M, Nahvijou A, Arab M, Sari AA. Mapping EORTC-QLQ-C30 and QLQ-CR29 onto EQ-5D-5L in colorectal cancer patients. J Gastrointest Cancer. 2020;51(1):196–203. doi:10.1007/s12029-019-00229-630977049
   PubMed Web of Science ®Google Scholar
• Byford S, Torgerson DJ, Raftery J. Cost of illness studies. BMJ. 2000;320(7245):1335. doi:10.1136/bmj.320.7245.133510807635
   PubMed Web of Science ®Google Scholar
• Knaul FM, Arreola-Ornelas H, Méndez-Carniado O, et al. Evidence is good for your health system: policy reform to remedy catastrophic and impoverishing health spending in Mexico. Lancet. 2006;368(9549):1828–1841. doi:10.1016/S0140-6736(06)69565-217113432
   PubMed Web of Science ®Google Scholar
• Organization WH. The World Health Report 2000: Health Systems: Improving Performance. World Health Organization; 2000.
   Google Scholar
• Xu X, Huang X, Zhang X, Chen L, editors. Family Economic Burden of Elderly Chronic Diseases: Evidence from China. Healthcare. Multidisciplinary Digital Publishing Institute; 2019.
   Google Scholar
• Xu X, Xu Z, Chen L, Li C. How does industrial waste gas emission affect health care expenditure in different regions of China: an application of Bayesian Quantile Regression. Int J Environ Res Public Health. 2019;16(15):2748. doi:10.3390/ijerph16152748
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang X, Xu X. Health insurance and long-term care services for the disabled elderly in China: based on CHARLS data. Risk Manag Healthc Policy. 2020;13:155. doi:10.2147/RMHP.S23394932161509
   PubMed Web of Science ®Google Scholar
• Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20(4):327. doi:10.3350/cmh.2014.20.4.32725548737
   PubMedGoogle Scholar
• Mohammadi Y, Baghestani E, Bahrami M, Entezarian AS, Ahmadi TG. Calculating the cost price of dialysis in Shahid Sadoughi hospital using activity based costing. Yazd. 2012;2011.
   Google Scholar
• Ghaffari S, Mohammadzadeh A, Soliman A, Salem SP, Yousefi M. Costing in Hospital Services: Economists and Accountants’approaches. Tehran University of Medical Sciences; 2013.
   Google Scholar
• Habetha S, Bleich S, Weidenhammer J, Fegert JM. A prevalence-based approach to societal costs occurring in consequence of child abuse and neglect. Child Adolesc Psychiatry Ment Health. 2012;6(1):35. doi:10.1186/1753-2000-6-3523158382
   PubMedGoogle Scholar
• Segel JE. Cost-of-illness studies—a primer. RTI-UNC center of excellence in health promotion economics. RTI International 2006;1:39.
   Google Scholar
• Taplin SH, Barlow W, Urban N, et al. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst. 1995;87(6):417–426. doi:10.1093/jnci/87.6.4177861461
   PubMedGoogle Scholar
• Lang H-C, Wu S-L. Lifetime costs of the top five cancers in Taiwan. Eur J Health Econ. 2012;13(3):347–353. doi:10.1007/s10198-011-0307-121442437
   PubMed Web of Science ®Google Scholar
• Hajebrahimi S, Ahari AM, Ghyassi FS, Mostafaie A, Yousefi M. Holmium laser prostate enucleation (HOLEP) versus trans-urethral resection of prostate (TURP) in treatment of symptomatic prostatic enlargement; a health technology assessment. J Lasers Med Sci. 2011;2(1).
   Google Scholar
• Organization WH. Non-Communicable Disease Prevention and Control: A Guidance Note for Investment Cases. World Health Organization; 2019.
   Google Scholar
• Peykari N, Hashemi H, Dinarvand R, et al. National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic. J Diabetes Metab Disord. 2017;16(1):3. doi:10.1186/s40200-017-0288-428127543
   PubMedGoogle Scholar
• Baker D, Stachenko S, Spasoff RA, Pogson M. 47 A method for comparing and combining cost-of-illness studies: an example from cardiovascular disease. Chronic Dis Can. 2002;23(2).
   Google Scholar
• Kim J, Lee E, Lee T, Sohn A. Economic burden of acute coronary syndrome in South Korea: a national survey. BMC Cardiovasc Disord. 2013;13(1):55. doi:10.1186/1471-2261-13-5523924508
   PubMed Web of Science ®Google Scholar
• Turner H. Introduction to Generalized Linear Models. Rapport technique, Vienna University of Economics and Business; 2008.
   Google Scholar
• Horton NJ, Laird NM. Maximum likelihood analysis of generalized linear models with missing covariates. Stat Methods Med Res. 1999;8(1):37–50. doi:10.1177/09622802990080010410347859
   PubMed Web of Science ®Google Scholar
• Organization WH. Noncommunicable Diseases Country Profiles 2018; 2018.
   Google Scholar
• Emamgholipour S, Sari AA, Pakdaman M, Geravandi S. Economic burden of cardiovascular disease in the Southwest of Iran. Int Cardiovasc Res J. 2018;12(1).
   Web of Science ®Google Scholar
• Walker IF, Garbe F, Wright J, et al. The economic costs of cardiovascular disease, diabetes mellitus, and associated complications in South Asia: a systematic review. Value Health Reg Issues. 2018;15:12–26. doi:10.1016/j.vhri.2017.05.00329474174
   PubMedGoogle Scholar
• Andrikopoulos G, Richter D, Sakellariou D, et al. High prevalence and diminished awareness of overweight and obesity in a mediterranean population. An alarming call for action. Open Cardiovasc Med J. 2012;6:141. doi:10.2174/187419240120601014123230452
   PubMedGoogle Scholar
• Sarrafzadegan N, Mohammadifard N. Cardiovascular disease in Iran in the last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention. Arch Iran Med. 2019;22(4):204–210.31126179
   PubMed Web of Science ®Google Scholar
• Chang H-S, Kim H-J, Nam C-M, et al. The socioeconomic burden of coronary heart disease in Korea. J Prev Med Public Health. 2012;45(5):291. doi:10.3961/jpmph.2012.45.5.29123091654
   PubMedGoogle Scholar
• Tomas A, Tomić Z, Milijašević B, et al. Patterns of prescription antihypertensive drug utilization and adherence to treatment guidelines in the city of Novi Sad. Vojnosanit Pregl. 2016;73(6):531–537. doi:10.2298/VSP141119047T27498444
   PubMed Web of Science ®Google Scholar
• Members WG, Thom T, Haase N, et al. Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113(6):e85–e151. doi:10.1161/CIRCULATIONAHA.105.17160016407573
   PubMed Web of Science ®Google Scholar
• Yang L, Wu M, Cui B, Xu J. Economic burden of cardiovascular diseases in China. Expert Rev Pharmacoecon Outcomes Res. 2008;8(4):349–356. doi:10.1586/14737167.8.4.34920528342
   PubMedGoogle Scholar
• Ngalesoni F, Ruhago G, Norheim OF, Robberstad B. Economic cost of primary prevention of cardiovascular diseases in Tanzania. Health Policy Plan. 2015;30(7):875–884. doi:10.1093/heapol/czu08825113027
   PubMed Web of Science ®Google Scholar
• Bramkamp M, Radovanovic D, Erne P, Szucs TD. Determinants of costs and the length of stay in acute coronary syndromes: a real life analysis of more than 10 000 patients. Cardiovasc Drugs Ther. 2007;21(5):389–398. doi:10.1007/s10557-007-6044-017805954
   PubMed Web of Science ®Google Scholar
• Daroudi A, Zendehdel K, Nahvijou A, Zahmatkesh H, Akbarisari A. A review of methods for estimating economic burden of cancer. 2014.
   Google Scholar
• Tabrizi JS, HaghGoshayie E, Doshmangir L, Yousefi M. New public management in Iran’s health complex: a management framework for primary health care system. Prim Health Care Res Dev. 2018;19(3):264–276. doi:10.1017/S146342361700076729310744
   PubMed Web of Science ®Google Scholar